Pharmafile Logo
Pharmafocus logo
Advanced Search

JJ

Showing 15 posts of 221 posts found.

China image

Merck and J&J invest in Chinese manufacturing

November 18, 2013
Manufacturing and Production J&J, JJ, Merck, manufacturing

Merck KGaA and Johnson & Johnson have both announced new manufacturing projects in China, suggesting investigations into corruption by the …

News
Johnson and Johnson image

J&J ‘to pay out $4 billion’ in fresh legal case

November 14, 2013
Sales and Marketing J&J, JJ, Risperdal, fines, hip replacement

Johnson & Johnson is set to pay up to $4 billion to settle thousands of legal cases related to patients …

News
J&J image

J&J hit with $2.2 billion fine

November 5, 2013
Sales and Marketing J&J, JJ, Janssen, Risperdal, antipsychotic, fine

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …

News
mark_mcclellan_jj_fda

Former FDA commissioner joins J&J

October 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, J&J, JJ

Johnson & Johnson has announced that ex-FDA commissioner Mark McClellan has been appointed to its Board of directors. Dr McClellan …

Appointment
jj_2johnson_and_johnson

Johnson & Johnson posts strong Q3 results

October 16, 2013
Sales and Marketing J&J, JJ, Q3, Velcade, results

Johnson & Johnson has posted a strong set of financials for the third quarter as new products from its pharma …

News

J&J partners with European biotech firms

October 4, 2013
Research and Development, Sales and Marketing J&J, JJ, effimune, life sciences, merus

The London Johnson & Johnson Innovation Centre has teamed up with several biotech partners from the European region. Announced at …

News
manufacturing_compounding

J&J’s prescription drugs unit hit by recall

September 17, 2013
Manufacturing and Production J&J, JJ, Risperdal, Tylenol, recalls

News

J&J’s manufacturing recovery hits a hurdle

September 10, 2013
Manufacturing and Production API, J&J, JJ, McNeil, Motrin, recall

Johnson & Johnson’s path back to regulatory compliance in its manufacturing operations has hit another snag after the firm was …

News
J&J image

J&J says revived OTC brands are ‘winning the hearts of consumers’

July 19, 2013
Manufacturing and Production, Sales and Marketing Control, FDA, GDP, J&J, JJ, OTC

Johnson & Johnson doesn’t usually provide specific financials for its over-the-counter pharmaceuticals business, but did so for the first time …

News
J&J image

J&J sees Q2 sales rise

July 17, 2013
Sales and Marketing Elan, J&J, JJ, Q2, Synthes, sales

Johnson & Johnson saw overall sales rise 8.5% year-on-year in the second quarter of 2013, with the US healthcare group …

News
J&J image

Next generation digital firms for Europe wanted

July 15, 2013
Medical Communications, Sales and Marketing J&J, JJ, digital, innovation

Digital health start-ups from across Europe are being called on to form a part of Johnson & Johnson Innovation’s inaugural …

News

J&J opens office at Stevenage Bioscience Catalyst

June 21, 2013
Manufacturing and Production, Research and Development J&J, JJ, bioscience, catalyst

Johnson & Johnson Innovation has establishment a partnering office at Stevenage Bioscience Catalyst to support emerging entrepreneurs and biotech firms …

News
J&J image

J&J to pay up to $1 billion in Aragon deal

June 18, 2013
Research and Development, Sales and Marketing Aragon, J&J, JJ, Zytiga

Johnson & Johnson could pay as much as $1 billion to buy prostate cancer specialist Aragon Pharmaceuticals. The acquisition includes …

News
johnson and johnson image

J&J recalls 32 million contraceptive packs

June 5, 2013
Manufacturing and Production Cilest, J&J, JJ, recall

Johnson & Johnson has announced a 43-country recall of its oral contraceptive Cilest and suspended production of the drug because …

News

South Korea eyeing criminal charges over J&J plant failures

May 17, 2013
Manufacturing and Production J&J, JJ, Janssen, Korea, MFDS

The chief executive of Johnson & Johnson’s South Korean subsidiary could be facing criminal charges over quality lapses at a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025